Highly increased CSF tau protein and decreased beta-amyloid (1-42) in sporadic CJD: a discrimination from Alzheimer's disease?
about
Cerebrospinal fluid biomarkers of Alzheimer’s diseaseBiomarkers of Alzheimer's diseaseRationale for diagnosing human prion disease.Decreased CSF transferrin in sCJD: a potential pre-mortem diagnostic test for prion disorders.A common BACE1 polymorphism is a risk factor for sporadic Creutzfeldt-Jakob diseaseBiomarkers in Alzheimer's disease.Gold-nanoparticle-decorated silica nanorods for sensitive visual detection of proteins.CSF tau and β-amyloid as biomarkers for mild cognitive impairment.A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease.CSF markers for Alzheimer's disease: total tau, phospho-tau and Abeta42.Cerebrospinal fluid protein biomarkers for Alzheimer's disease.Mathematical model on Alzheimer's diseaseRaised CSF phospho-tau concentrations in variant Creutzfeldt-Jakob disease: diagnostic and pathological implications.How proteomics reveals potential biomarkers in brain diseases.Cerebrospinal fluid tau, A beta, and phosphorylated tau protein for the diagnosis of Alzheimer's disease.Current state and future directions of neurochemical biomarkers for Alzheimer's disease.Tau-based treatment strategies in neurodegenerative diseasesCerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly.Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants.Plasma Tau Levels in Cognitively Normal Middle-Aged and Older Adults.Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels.Biomarkers of Alzheimer's disease in body fluids.Tau and p-tau as CSF biomarkers in dementia: a meta-analysis.The development of effective biomarkers for Alzheimer's disease: a review.Proteomic analysis of prion diseases: creating clarity or causing confusion?Cerebrospinal Fluid Amyloid-β 42, Total Tau, and Phosphorylated Tau are Low in Patients with Normal Pressure Hydrocephalus: Analogies and Differences with Alzheimer's Disease.Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review.Plasma tau as a window to the brain-negative associations with brain volume and memory function in mild cognitive impairment and early Alzheimer's disease.Hyperphosphorylated tau protein in the cerebrospinal fluid of patients with Alzheimer's disease and other dementias: preliminary findings.Unusual features of Creutzfeldt-Jakob disease followed-up in a memory clinic.The diagnostic value of cerebrospinal fluid tau protein in dementing and nondementing neuropsychiatric disorders.Proteomic analysis of the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.Serum tau protein as a marker for the diagnosis of Creutzfeldt-Jakob disease.Follow-up investigations of tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.Added Diagnostic Value of Cerebrospinal Fluid Biomarkers for Differential Dementia Diagnosis in an Autopsy-Confirmed Cohort.
P2860
Q22252572-7FCE4257-451E-44D8-9CE9-6BE7BD263877Q24650667-50164CE6-4C0F-4E0E-8C37-3A4A441B97F8Q30936688-454BB23A-3F7E-419B-B142-8E740EF0444FQ33847248-16635D9D-25C7-40F5-B452-7C9E959F24DBQ34405864-F08DB89B-E219-497F-9AC5-92CDF930E375Q35113795-77A021CB-3B50-42D3-985C-AFA8C6B24C18Q35213057-20B18EAC-7331-43C8-9792-927738D70771Q35236838-DDA7A6BE-FD9F-4C54-B57D-A648DD4A6B51Q35476014-9B032154-39CB-4A98-8103-513F43233830Q35580179-7A37D846-CD8C-47FF-96C0-ACBF7B200E2FQ36045282-56E0717C-5E35-4D69-BFD7-48AF2B7A036CQ36198218-CBCF1516-1B40-4254-96CF-D029E4701397Q36226169-620439E3-0404-4BB9-A12B-E78C9EAD41F7Q36322155-56769A9D-6BB7-443A-89DA-2B89345F6343Q36382217-A35117A6-7D25-4CCB-B70B-F9ABADA1A470Q36985933-22E48821-0028-455C-9ABF-64DD4AE84382Q37215861-A750D623-D60A-4147-89EE-733CD0A08133Q37524486-42241B9F-E619-459C-8CDD-E03213AAE8F9Q37530397-820E91C5-1CDB-4314-A5CD-583A75353E1AQ37681181-56ACBA46-1A5B-4A3A-91AB-085E95C95717Q37697455-7BDD7432-9F04-4D6F-957A-8E752CBA6C5EQ37769463-D2EFFDDD-5043-4523-944E-C82EFC2DA5E3Q37845820-CB8BC5CE-28B9-495B-B5DB-1A3F3756A510Q38016800-123A571E-8C04-4E39-9092-90F163F167FDQ38060590-CDD94C29-8598-4999-BEA1-35B959C11887Q38616051-2EF53B8D-D007-4354-A31E-6081AB322F50Q38963731-CFC27D91-AE4D-4D52-ACA6-70025403D86DQ43863392-F23A30B8-BAC2-4C96-92BA-5A0BCF01DEB3Q45099824-B52ED3A1-0F51-4AC0-AE9E-F6B2F66E6A24Q48361950-848BE1B5-2446-4DB4-8197-2A9000ECCF9BQ51926890-8F5CA15D-04BD-40E6-BB6C-66770630FF21Q51930123-7AC1862E-5C94-4F0F-A3C2-B2E5FFAA2BDFQ53317130-A7C03C4A-8CA6-42BC-B06E-E464057000CAQ53370121-FE313433-E5F5-46FA-8ECB-138D0EB6851AQ53419197-77D2DEDD-9F56-4EC6-A0EF-C2EF988CB2D1
P2860
Highly increased CSF tau protein and decreased beta-amyloid (1-42) in sporadic CJD: a discrimination from Alzheimer's disease?
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Highly increased CSF tau prote ...... tion from Alzheimer's disease?
@ast
Highly increased CSF tau prote ...... tion from Alzheimer's disease?
@en
type
label
Highly increased CSF tau prote ...... tion from Alzheimer's disease?
@ast
Highly increased CSF tau prote ...... tion from Alzheimer's disease?
@en
prefLabel
Highly increased CSF tau prote ...... tion from Alzheimer's disease?
@ast
Highly increased CSF tau prote ...... tion from Alzheimer's disease?
@en
P2093
P356
P1476
Highly increased CSF tau prote ...... tion from Alzheimer's disease?
@en
P2093
Kilidireas K
Michalopoulou M
Paraskevas GP
Patsouris E
P304
P356
10.1136/JNNP.71.3.401
P407
P577
2001-09-01T00:00:00Z